NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/25/2022
Back to search
Official data from USPTO
EXOVECTORY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EXOVECTORY
ST13
US500000090899241Class
5, 42
Filing
90899241
Registration
6883238
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
10/25/2022
Trademark type
Word
Nice classes
5, 42
Filing date
08/24/2021
Registration date
10/25/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/25/2022
Last transaction
10/25/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
HA Leidschendam, NL
Examiner
BRACEY, KAREN
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ExoVectory B.V.
Representatives
Nicholas D. Wells LEGENDS LAW GROUP, PLLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drug delivery systems in the nature of exosomes for use in gene therapy to deliver pharmaceutical and natural remedy preparations used to treat a wide variety of diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Medicines for cancerdiabetesdiseases of the heart and lungsdiseases of the blood and bonesdiseases of the skindiseases of the braindiseases of the kidneys and reproductive systemsdiseases of the jointsdiseases of the earnosethroatdiseases of the eye; Anti-cancer drugs; Diagnostic testing strips for testing bloodurinesaliva for medical use; Biotechnological preparations in the nature of chemical reagents comprising gene therapies used to deliver medications to patients for treatment of a wide variety of diseases for medical use; Vaccines; Reagents for use in medical genetic testing; Pharmaceutical products for the treatment of infectious diseases
Class 42
Medical and pharmacological research services; Scientific research in the field of pharmacy; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Laboratory research services relating to pharmaceuticals; Scientific research for medical purposes in the area of cancerous diseases; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research relating to biotechnology; Research and development of vaccines and medicines; Scientific research in the field of genetics
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/25/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/09/2022
PUBO
PUBLISHED FOR OPPOSITION
08/09/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/20/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/07/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
07/07/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/07/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
07/07/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/29/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/29/2022
ALIE
ASSIGNED TO LIE
06/28/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/16/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/27/2022
GNRT
NON-FINAL ACTION E-MAILED
05/27/2022
CNRT
NON-FINAL ACTION WRITTEN
05/27/2022
DOCK
ASSIGNED TO EXAMINER
05/26/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/10/2021
NWAP
NEW APPLICATION ENTERED
08/27/2021
Continuous trademark protection
Get notified about every new filing that threatens EXOVECTORY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.